Happy Health snags $75M to support home-based care. Happy Health's $75 million round was from ARCH Venture Partners and OpenLoop. Happy Health, a health platform for at-home monitoring, announced Tuesday that it raised $75 million to support the transition to home-based care. The Texas-based company offers an FDA-cleared smart ring for at-home diagnosis of obstructive sleep apnea. It also provides treatment management and daily sleep health measurements. Happy Health's platform uses continuous health data and AI to create a personalized baseline for each patient, helping doctors identify meaningful changes in their health. Sleep is the company's first focus area, but it plans to expand into other areas in the future. "Our bigger vision is precision diagnostics that live on your finger and enable care across many conditions from the comfort of patients' home," said Dr. Dustin Freckleton, founder and CEO of Happy Health. presented by What if health plans could identify member decline before an avoidable hospitalization occurs? Real-time clinical visibility into long-stay SNF members uncovers risk earlier and drives better outcomes. The $75 million round was from ARCH Venture Partners and OpenLoop. The financing will help Happy Health accelerate the clinical validation of its tech, as well as build the infrastructure to expand beyond sleep, Freckleton told MedCity News. Happy Health is supporting the shift toward more proactive care, according to ARCH Venture Partners. "For decades, healthcare has waited until people are already sick to act," said Paul Berns of ARCH Venture Partners in a statement. "Happy Health is showing that many diagnoses may never need to happen inside a hospital at all. By combining continuous physiological monitoring with physician-guided care, they're proving what care can look like when it moves into the home." Currently, the healthcare system is organized around episodic visits, often discovering chronic diseases too late, according to Freckleton. Sleep apnea is an example of this. presented by In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable. "It's a pervasive health disorder that amplifies nearly every serious downstream condition: cardiovascular disease, stroke, AFib, all-cause mortality," he said. "There's one sleep doctor for every 43,000 Americans, and a 3-4 month wait to get into a clinic. So 80% of people who have it don't know it. There are many treatment options available for sleep apnea, which will in turn mitigate development of other chronic conditions, but you can't get care if you aren't diagnosed." Freckleton has experienced these issues firsthand. He had a stroke at the age of 24 and didn't receive a diagnosis for sleep apnea for another seven years, despite it being a common stroke risk factor. Happy Health isn't the only company offering a wearable ring that tracks sleep. Oura also offers a ring that provides users with insights into their sleep and other health metrics, but unlike Happy Health's ring, Oura's is not a medical device and is not intended to diagnose medical conditions. Ultimately, Happy Health aims to "enable continuous monitoring at home so we can detect disease earlier and give physicians the opportunity to intervene before conditions become more serious," Freckleton said.

Happy Health, an Austin-based digital health company, secured $75 million in Series A funding led by ARCH Venture Partners and OpenLoop to expand its AI-powered home care platform. The startup's FDA-cleared Happy Ring is the first smart ring approved for multi-night sleep testing and continuous biometrics. It diagnoses obstructive sleep apnea and insomnia in as few as three nights with 98% accuracy, according to the company. The platform collects over 2.8 million biometric measurements nightly, building individualised physiological baselines rather than comparing patients to population averages. Happy Sleep includes board-certified sleep physicians and accepts most major insurance plans, including Blue Cross and Medicare. The company plans to extend its continuous monitoring approach to cardiovascular, metabolic, and other chronic diseases.

Opendoor Technologies reported second-quarter results showing revenue of $883 million, down from $1,567 million year-over-year. Net loss widened to $162 million, with loss per share from continuing operations at $0.17. The company noted a 149% year-over-year increase in homes acquired and early traction in its new mortgage product. Management expects at least 20% revenue growth in the third quarter and aims for adjusted net income profitability by year-end 2026. The results highlight tensions in Opendoor's business model, as it attempts to rebuild scale whilst managing inventory and funding risks. Six-month losses totalled $335 million. The company's debt-funded inventory model continues to face scrutiny from investors concerned about liquidity and margins.